Latest News in the pharma Industry

Top Stories

The new age of regenerative medicine: why stem cell therapy?

The new age of regenerative medicine: why stem cell therapy?

18 Sep 2015

Frost & Sullivan webinar reveals stem cell therapy pipeline and treatments innovating regenerative medicine.

Read more 
Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

17 Sep 2015

Findings from a head-to-head trial comparing Victoza (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 ...

Read more 
Impax receives FDA approval for generic version of Mestinon Timespan Tablets,     180 mg

Impax receives FDA approval for generic version of Mestinon Timespan Tablets, 180 mg

17 Sep 2015

First generic product approved from Hayward manufacturing facility following recent resolution of Warning Letter

Read more 
Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

17 Sep 2015

Omarigliptin was found to be non-inferior to Merck’s once-daily DPP-4 inhibitor, Januvia (sitagliptin), at reducing patients’ A1C levels from baseline, with similar A1C reductions achieved in both groups.

Read more 
Using proteomics to understand how genetic mutations rewire cancer cells

Using proteomics to understand how genetic mutations rewire cancer cells

17 Sep 2015

Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells

Read more 
Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria

Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria

17 Sep 2015

BioInject is a state-of-the-art facility that will be used to manufacture pre-filled syringes and devices for both Sandoz’s biosimilars and Novartis Pharma’s novel biologics.

Read more 
Technical knowledge alone is not enough for pharmaceutical professionals

Technical knowledge alone is not enough for pharmaceutical professionals

16 Sep 2015

Pharmaceutical professionals must develop wider commercial and business skills if they want to continue to secure the top jobs, according to NonStop Recruitment.

Read more 
Amgen to acquire privately-held Dezima Pharma

Amgen to acquire privately-held Dezima Pharma

16 Sep 2015

Dezima's lead molecule is TA-8995, an oral, once-daily cholesteryl ester transfer protein (CETP) inhibitor.

Read more 
BMS’s Opdivo (nivolumab) receives breakthrough therapy designation from FDA for advanced renal cell carcinoma

BMS’s Opdivo (nivolumab) receives breakthrough therapy designation from FDA for advanced renal cell carcinoma

16 Sep 2015

This is the fourth Breakthrough Therapy Designation granted for Opdivo by the FDA

Read more 
Post purification sample handling

Post purification sample handling

16 Sep 2015

Genevac has developed a suite of proprietary technological solutions to facilitate post purification sample handling, including reformatting.

Read more 
Horizon Discovery Group enters bioproduction cell line licensing agreement with LakePharma

Horizon Discovery Group enters bioproduction cell line licensing agreement with LakePharma

16 Sep 2015

The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma.

Read more 
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline

AstraZeneca purchases US biologics manufacturing facility to support growing pipeline

16 Sep 2015

The LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines.

Read more